TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,276,959 | +10.2% | 91,665 | -33.3% | 0.01% | +14.3% |
| Q1 2023 | $2,066,000 | -5.5% | 137,367 | +19.4% | 0.01% | +16.7% |
| Q4 2021 | $2,186,000 | -45.7% | 115,060 | -4.8% | 0.01% | -50.0% |
| Q3 2021 | $4,023,000 | +36.4% | 120,883 | +59.0% | 0.01% | +20.0% |
| Q2 2021 | $2,949,000 | -5.9% | 76,029 | +17.0% | 0.01% | -9.1% |
| Q1 2021 | $3,133,000 | -17.0% | 65,006 | -10.4% | 0.01% | -15.4% |
| Q4 2020 | $3,774,000 | +51.9% | 72,549 | -21.9% | 0.01% | +30.0% |
| Q3 2020 | $2,485,000 | +27.8% | 92,874 | -6.9% | 0.01% | +25.0% |
| Q2 2020 | $1,944,000 | – | 99,782 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |